Similar to "define_variable_has_no_data", we need an operator "define_dataset_has_no_data" in order to be able to tackle FDA business rules FB6602, FB6510, FB6508, FB6507, FB6506, FB6505, FB6504, ...
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, has announced their collaboration with the Clinical Data Interchange ...
More than 233,000 bottles of an antidepressant have been recalled by public health officials due to a chemical containing the risk of cancer. The U.S. Food and Drug Administration classified capsules ...
The Food and Drug Administration declined to approve MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, drugmaker Lykos Therapeutics said Friday. Experts and advocates ...
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain's decline ...
The Food and Drug Administration’s Center for Tobacco Products (CTP), in partnership with the Clinical Data Interchange Standards Consortium (CDISC), has released a new resource to help facilitate ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...
AUSTIN, Texas--(BUSINESS WIRE)--CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and ...
CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and Research and Office of ...
Add Silicon Canals to your Google News feed. AUSTIN, Texas–(BUSINESS WIRE)–CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer ...
The FDA’s Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023, as the small molecule and biologic pharmacopoeia continues to grow. This cohort is nearly 50% bigger than the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results